Moneycontrol PRO
HomeHealth & FitnessCOVID-19 surge in Asia: Causes, symptoms and prevention tips for the JN.1 variant

COVID-19 surge in Asia: Causes, symptoms and prevention tips for the JN.1 variant

JN.1 variant in India: JN.1 may not be more severe, but it spreads fast, and that’s reason enough to stay alert. Across Asia, the priority is clear: stay prepared, stay informed, and use lessons from past outbreaks to keep ahead of the virus.

May 19, 2025 / 17:47 IST
COVID-19 JN.1 variant symptoms: JN.1 is a fast-spreading subvariant of Omicron, now dominant in several parts of Asia. Symptoms of COVID-19 JN.1 variant include nclude fever, dry cough, fatigue, sore throat, nasal congestion, and occasional shortness of breath

A new COVID-19 variant, JN.1, is driving a fresh wave of infections across Asia, raising concerns among health experts and governments. As a subvariant of Omicron, JN.1 is known for spreading quickly, particularly in densely populated regions. With cases rising, authorities are closely monitoring its impact and urging precautions.

According to the World Health Organization (WHO), JN.1 is classified as a variant of interest. This means it shows genetic changes that could affect its transmissibility or severity and is being closely monitored. The WHO has noted its rapid spread in several regions but confirmed there is no clear evidence that it causes more severe illness.

Cases linked to JN.1 are rising sharply in parts of Asia, including India, China, Singapore, and other Southeast Asian countries. Although symptoms are generally mild, the sheer number of infections could strain hospitals. In response, many countries are increasing testing, updating travel advisories, and encouraging booster vaccinations.

Also read | Fresh Covid-19 wave hits Asia; Singapore and Hong Kong see surge: Is India at risk too?

The variant’s ability to partially evade immunity from previous infections or vaccines adds to concerns. Though lockdowns are unlikely, public health systems are taking preventive steps to manage the spread.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Here’s what you need to know about JN.1 in Asia:

  • The spread: JN.1 is a fast-spreading subvariant of Omicron, now dominant in several parts of Asia. Countries reporting rising cases include India, China, Singapore, Thailand, and Malaysia. It's especially active in urban, crowded environments where the virus can travel quickly.

  • Symptoms of COVID-19 JN.1 variant: Symptoms are similar to earlier COVID-19 variants. Most commonly, they include fever, dry cough, fatigue, sore throat, nasal congestion, and occasional shortness of breath. Many people experience mild illness, especially if vaccinated.

  • Causes of COVID-19 surge: Its high transmissibility is linked to changes in the spike protein that make it easier to infect others. Indoor gatherings, international travel, and reduced public health measures are also contributing to the variant’s rapid rise.

Also read | Bigg Boss 18's Shilpa Shirodkar tests Covid Positive, asks fans to wear masks
  • Health risks: Older adults, people with weakened immune systems, and those with chronic health conditions remain at higher risk of complications. Children and unvaccinated people may also face increased vulnerability if community spread continues.

  • How to prevent COVID-19 JN.1 variant: Preventive ways:Boosters are key, especially updated COVID-19 vaccines that target newer variants. Other measures include wearing masks in crowded spaces, improving indoor ventilation, frequent handwashing, and avoiding close contact when ill. Staying informed is also essential.
Disclaimer: This article, including health and fitness advice, only provides generic information. Don’t treat it as a substitute for qualified medical opinion. Always consult a specialist for specific health diagnosis.
Namita S Kalla is a senior journalist who writes about different aspects of modern life that include lifestyle, health, fashion, beauty, and entertainment.
first published: May 19, 2025 05:47 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347